These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10968553)

  • 21. Challenges in Implementing a Biorisk Management Program at Universitas Indonesia: A Checklist Tool for Biorisk Management.
    Naroeni A; Bachtiar EW; Ibrahim F; Bela B; Kusminanti Y; Pujiriani I; Lestari F
    Health Secur; 2016; 14(6):375-381. PubMed ID: 27830940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biosafety considerations for autopsy.
    Nolte KB; Taylor DG; Richmond JY
    Am J Forensic Med Pathol; 2002 Jun; 23(2):107-22. PubMed ID: 12040252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Occupational standards for the protection of employees in biotechnology.
    Eckebrecht T
    Int Arch Occup Environ Health; 2000 Jun; 73 Suppl():S4-7. PubMed ID: 10968552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biocontainment laboratory risk assessment: perspectives and considerations.
    Patterson A; Fennington K; Bayha R; Wax D; Hirschberg R; Boyd N; Kurilla M
    Pathog Dis; 2014 Jul; 71(2):102-8. PubMed ID: 24591404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Smart Card Decontamination in a High-Containment Laboratory.
    Gabbert LR; Smith JD; Neilan JG; Ferman GS; Rasmussen MV
    Health Secur; 2018; 16(4):244-251. PubMed ID: 30096256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biosafety: guidelines for working with pathogenic and infectious microorganisms.
    Coico R; Lunn G
    Curr Protoc Immunol; 2005 Nov; Appendix 1():A.1V.1-A.1V.8. PubMed ID: 18432937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Good and bad examples of siting and building biosafety level 4 laboratories: a study of Winnipeg, Galveston and Etobicoke.
    Löfstedt R
    J Hazard Mater; 2002 Jul; 93(1):47-66. PubMed ID: 12062953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving the biosafety of cell sorting by adaptation of a cell sorting system to a biosafety cabinet.
    Lennartz K; Lu M; Flasshove M; Moritz T; Kirstein U
    Cytometry A; 2005 Aug; 66(2):119-27. PubMed ID: 15973698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Government regulation of nonhuman primate facilities.
    Meyers NM
    J Med Primatol; 1983; 12(4):169-83. PubMed ID: 6680143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishment of Biosafety Level-3 (BSL-3) laboratory: important criteria to consider while designing, constructing, commissioning & operating the facility in Indian setting.
    Mourya DT; Yadav PD; Majumdar TD; Chauhan DS; Katoch VM
    Indian J Med Res; 2014 Aug; 140(2):171-83. PubMed ID: 25297350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biosafety and Biohazards: Understanding Biosafety Levels and Meeting Safety Requirements of a Biobank.
    Ta L; Gosa L; Nathanson DA
    Methods Mol Biol; 2019; 1897():213-225. PubMed ID: 30539447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biocontainment design considerations for biopharmaceutical facilities.
    Miller SR; Bergmann D
    J Ind Microbiol; 1993 Jul; 11(4):223-34. PubMed ID: 7763894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infectious waste management and laboratory design criteria.
    Zaki AN; Campbell JR
    Am Ind Hyg Assoc J; 1997 Nov; 58(11):800-8. PubMed ID: 9373926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biosafety concerns for shared flow cytometry core facilities.
    Schmid I; Merlin S; Perfetto SP
    Cytometry A; 2003 Dec; 56(2):113-9. PubMed ID: 14608639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biosafety and biosecurity measures: management of biosafety level 3 facilities.
    Zaki AN
    Int J Antimicrob Agents; 2010 Nov; 36 Suppl 1():S70-4. PubMed ID: 20801002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Main Biological Hazards in Animal Biosafety Level 2 Facilities and Strategies for Control.
    Li XY; Xue KN; Jiang JS; Lu XC
    Biomed Environ Sci; 2016 Apr; 29(4):300-4. PubMed ID: 27241742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Update on Biosafety and Emerging Infections for the Clinical Microbiology Laboratory.
    Pentella MA
    Clin Lab Med; 2020 Dec; 40(4):473-482. PubMed ID: 33121616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laboratory Focus on Improving the Culture of Biosafety: Statewide Risk Assessment of Clinical Laboratories That Process Specimens for Microbiologic Analysis.
    Munson E; Bowles EJ; Dern R; Beck E; Podzorski RP; Bateman AC; Block TK; Kropp JL; Radke T; Siebers K; Simmons B; Smith MA; Spray-Larson F; Warshauer DM
    J Clin Microbiol; 2018 Jan; 56(1):. PubMed ID: 29118166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microbiological safety cabinets: selection, installation, testing and use.
    Kennedy DA; Collins CH
    Br J Biomed Sci; 2000; 57(4):330-7. PubMed ID: 11204866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defining and managing biohazardous waste in U.S. research-oriented universities: a survey of environmental health and safety professionals.
    Mecklem RL; Neumann CM
    J Environ Health; 2003; 66(1):17-22. PubMed ID: 12879576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.